Assessment System of Sarcopenia in Lung Cancer Patients
Recruiting · NCT06327594 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
CT/MRI scanultrasound scan
What this trial is about
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
Who can take part
Age range
40 Years to 100 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Hospitalized patients scheduled for radical resection of lung cancer.
- With a CT/MRI examination within 1 week.
- The compliance of examination was good.
Exclusion criteria
- Amputated arm or leg.
- Severe oedema (oedema higher than knee level).
- Implantable pacemaker.
- Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.
Where it is running
1 location listed.
- Xinyi Tang - Chengdu, Sichuan, China